Upgrade to SI Premium - Free Trial

Catalent (CTLT) PT Raised to $137 at RBC Capital, 'COVID-Related Programs Continue to Drive FY21 Outlook Higher'

February 2, 2021 4:20 PM
RBC Capital analyst Sean Dodge raised the price target on Catalent (NYSE: CTLT) to $137.00 (from $125.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles